Vera Therapeutics, Inc. - 8-K Filing
Vera Therapeutics appoints Nancy Bowman as new Chief Regulatory Officer effective August 3, 2026; William Turner transitions to Special Advisor for Regulatory Affairs. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi)
Tickers: $VERA